Studies have shown that rebamipide can fight the damaging effects of [[Nonsteroidal anti-inflammatory drug|NSAIDs]] on the [[gastro-intestinal tract|GIT]] mucosa, and more recently, the small intestine.{{citation needed|date=October 2013}} It has also been studied for the treatment of [[Behçet's disease]].<ref>{{cite journal |vauthors=Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka S, Kogure M, Mizushima Y | title=Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behcet's disease: a randomised, double-blind, placebo-controlled study | journal=Drugs R D | year=2003 | pages=19–28 | volume=4 | issue=1  | pmid=12568631 | doi=10.2165/00126839-200304010-00002}}</ref> It was shown to successfully treat [[pouchitis]] in a single-N study after first-line therapies for the condition were unsuccessful.<ref>http://www.wjgnet.com/1007-9327/12/656.pdf
